Kraynyak KA, Blackwood E, Agnes J, Tebas P, et al. SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial. J Infect Dis 2022 Jan 25. pii: 6515374. doi: 10.1093.
PMID: 35079784